Cannabis Financial Network Podcast: The US Cannabis Market: New Promise, Persistent Constraints
In this episode…
FDA Approves GW Pharma’s Epidiolex
Impact on rescheduling cannabis and DEA’s rescheduling possibilities (isolate vs. cannabis plant)
Resulting investment plays (cannabinoid drug developers, hemp extracts)
Legalization Roundtable: State cannabis programs are flourishing (on both coasts) and fairing well under the Trump Administration on a macro level in light of the Cole Memo rescission, but federal restraints persist
